Author Archive: George Goodno

George Goodno

George is the Director of State Policy Communications at BIO and enjoys the opportunity to advocate for and educate audiences about the positive societal and economic impact of the bioscience industry. Another great aspect of his job is getting to work with BIO’s broad network of state bioscience associations to help advance legislative and regulatory initiatives that will continue to improve this high-skill, high-wage industry. In his spare time, he enjoys running, skiing, hiking, gardening, and most of all, spending time with his awesome wife and two daughters.

Follow him on Twitter @ggoodno

 

Latest Posts

Sen Menendez Asks SEC to Investigate IPR Abuses

Securities and Exchange Commission

New Jersey Senator Bob Menendez has asked the Securities and Exchange Commissioner (SEC) to investigate a new investment scheme designed to manipulate the stock prices of companies engaged in research and development of innovative medical therapies, to determine if the practice is illegal. As reported in this Bloomberg Business article, certain investment firms are shorting the stocks of patent-dependent life sciences companies and then using new patent litigation procedures to challenge their patents and drive Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

2015 BIO Legislative Day Fly-In

BIO_FLY-IN

More than 300 biotechnology industry representatives from over 40 states, representing hundreds of thousands of American workers, participated in hundreds of meetings with Members of the House and Senate during the BIO Legislative Day Fly-In. Participants discussed issues critical to the biotechnology industry including, drug development, discovery and delivery reforms, targeting abuses of the U.S. patent system while protecting innovation, providing adequate reimbursement for vital therapies under Medicare, FDA funding, tax policy, support for science-based Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Virginia Bio Announces Conference Featuring Gov. McAuliffe

vabio

Virginia Bio has announced that its bioscience centered THRiVE 2015 Conference will feature a Governor’s Forum on Bio and Big Data/Analytics. “We are proud to present this opportunity for direct interaction with some of the most influential thought leaders in the bioscience industry.” Jeffrey M. Gallagher, CEO, Virginia Bio Click Here to Register Virginia’s own Governor Terry McAuliffe will be on hand, as will bioscience leaders from across the state and beyond – including companies, universities, Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Asia International Conference Kicks Off Today

logo

The 12th Annual BIO Asia International Conference kicks off today (or tomorrow based on your time zone). The conference features private, pre-arranged one-on-one meetings between senior-level executives, using BIO’s proprietary, state-of-the-art computer software. The format and selective nature of the conference makes this the premier dedicated biotech partnering event in Asia and an unrivaled opportunity to meet with the leading international pharmaceutical and biotech companies in one place at one time. To see the most Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , ,

BIO Chair Testifies Before Senate

BIO’s Chair and CEO of GlycoMimetics, Rachel King

BIO’s Chair and CEO of GlycoMimetics, Rachel King, testified before the Senate Committee on Small Business and Entrepreneurship today where she reinforced the need for patent protection incentives to encourage small business innovation. Ms. King also encouraged Congress to address weaknesses in the United States Patent and Trademark Office’s Inter Partes Review (IRP) system that allows abuses perpetrated against legitimate patent holders. Read her full testimony. You can read more about BIO’s position on patent Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,